LearnDrugs.com
Nervous

Tricyclic Antidepressants (TCAs)

High-yield Verified · Jul 2026

Prototype: amitriptyline

TCAs — potent but old antidepressants whose side-effect load and overdose lethality moved them to second line.

How it works in the body

The system involved, what goes wrong, and how the drug and body interact.

01 Effective, but not selective — "dirty drugs"

TCAs also raise serotonin and norepinephrine by blocking their reuptake — so they work for depression. The problem is they are not selective: they also block muscarinic (cholinergic), histamine (H1), and alpha-1 adrenergic receptors. Each unwanted block produces its own side effect — anticholinergic (dry mouth, constipation, urinary retention, blurred vision), antihistamine (sedation, weight gain), and alpha (orthostatic hypotension).

That side-effect burden — and their danger in overdose — is why SSRIs/SNRIs replaced them as first-line. But TCAs remain valuable for neuropathic pain, migraine prophylaxis, and (low-dose) insomnia, where the same properties are useful.

TCAs hit four receptor systems — one therapeutic, three that generate side effects.

02 Why overdose is a code — cardiotoxicity

The single most important TCA fact: they are lethal in overdose, and depressed patients are exactly the population at risk. In overdose, TCAs block cardiac sodium channels (a local-anesthetic effect), which widens the QRS on the ECG and causes ventricular arrhythmias, seizures, and hypotension — the "three Cs": Coma, Convulsions, Cardiotoxicity.

A QRS > 100 ms predicts serious toxicity, and the antidote is IV sodium bicarbonate (it overcomes the sodium-channel block and alkalinizes). Because a week’s supply can be fatal, prescribers limit quantities — a key safety consideration in depressed patients.

TCA overdose blocks cardiac sodium channels → wide QRS/arrhythmia; antidote is sodium bicarbonate.

Drug names

Generic Brand
amitriptyline Elavil
nortriptyline Pamelor
imipramine Tofranil

Indications

  • Major depression (second-line, after SSRIs/SNRIs)
  • Neuropathic pain and migraine prophylaxis (low dose)
  • Other: insomnia (low-dose), nocturnal enuresis (imipramine), OCD (clomipramine)

Mechanism of action

Block reuptake of serotonin and norepinephrine (antidepressant effect) while also antagonizing muscarinic, histamine-H1, and alpha-1 adrenergic receptors (the anticholinergic, sedative, and orthostatic side effects). In overdose, cardiac sodium-channel blockade causes cardiotoxicity.

In plain terms
They boost mood chemicals like SSRIs, but also hit several other receptors — causing more side effects and, in overdose, dangerous heart effects.

Therapeutic effects — what you'll see working

Mood benefit takes 2–4 weeks; pain benefit can be earlier at lower doses. The whole safety story is minimizing anticholinergic/orthostatic effects and preventing overdose.

Antidepressant effect Neuropathic pain / migraine prevention
Antidepressant effect
Serotonin/norepinephrine reuptake block relieves depression over weeks — as effective as SSRIs but less well tolerated.
Neuropathic pain / migraine prevention
At lower doses than for depression, TCAs reduce neuropathic pain and prevent migraines.

Adverse effects

The everyday effects are the three "off-target" receptor blocks; the emergency is overdose cardiotoxicity, and the class carries the antidepressant suicidality boxed warning.

Caution: Common Expected
Anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision), sedation, weight gain, orthostatic hypotension.
These trace to muscarinic, H1, and alpha-1 blockade. Elders are especially vulnerable (falls, confusion, retention) — TCAs are on the Beers list.
Warning: Serious Report immediately
Overdose cardiotoxicity (wide QRS, ventricular arrhythmia), seizures, coma; QT prolongation; serotonin syndrome with other serotonergic drugs.
Overdose is potentially fatal — the "three Cs" (coma, convulsions, cardiotoxicity). A QRS > 100 ms signals danger; the antidote is IV sodium bicarbonate. Limit dispensed quantities in at-risk patients.
Black-box warning — most severe: ■ Boxed warning · suicidality
Increased suicidal thinking/behavior in patients < 25 early in treatment.
The antidepressant class warning applies; combined with overdose lethality, this makes suicide-risk assessment essential.

Antidote

Sodium bicarbonate (IV)
For overdose cardiotoxicity — TCAs are lethal in overdose (narrow therapeutic index): cardiac sodium-channel blockade widens the QRS (> 100 ms) and causes ventricular arrhythmia. IV sodium bicarbonate overcomes the block. Limit dispensed quantities in at-risk patients.

Contraindications

The contraindications are the cardiac and anticholinergic-sensitive states, plus the MAOI combination.

Recent myocardial infarction / significant conduction disease or arrhythmia
TCAs slow cardiac conduction and are proarrhythmic — dangerous in a compromised heart.
Concurrent MAOIs (or within 14 days)
Risk of severe serotonin syndrome and hypertensive crisis.
Narrow-angle glaucoma, BPH/urinary retention, severe constipation use caution
Anticholinergic effects worsen all of these.

Nursing considerations

The RN-specific layer — each action paired with the reason it matters.

Safety & monitoring
Assess suicide risk and consider limiting the dispensed quantity; obtain a baseline ECG in older/cardiac patients.
Why: A modest overdose can be fatal, and TCAs affect cardiac conduction.
Manage anticholinergic and orthostatic effects; rise slowly.
Why: Dry mouth, constipation, retention, and orthostasis are common and cause falls, especially in elders.
Patient teaching
Explain the 2–4 week onset, do not stop abruptly, and keep the drug secured away from children.
Why: Delayed benefit risks early discontinuation; a small pediatric ingestion can be lethal.

Sources

Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.